Jungmin Choi

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Scott Gettinger, Jungmin Choi, Katherine Hastings et al. · Cancer Discovery · 2017 · 755 citations · Full text

Life Sciences, Immunology, Oncology +17

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

Kurt A. Schalper, María E. Rodríguez-Ruiz, Ricardo Díez-Valle et al. · Nature Medicine · 2019 · 660 citations

Medicine, Immunology, Oncology +16

Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening

Bridget Stuart, Jungmin Choi, Samir Zaidi et al. · Nature Genetics · 2015 · 467 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Katherine Hastings, Helena A. Yu, Wen Wei et al. · Annals of Oncology · 2019 · 370 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling

Joseph M. Chan, Samir Zaidi, Jillian R Love et al. · Science · 2022 · 357 citations · Full text

Medicine, Cell Biology, Oncology +17